Daiwa Securities Group
AZN icon

Daiwa Securities Group’s AstraZeneca AZN Stock Holding History

Daiwa Securities Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,030
Closed -$4.97M – 1218
2025
Q4 		$4.97M Buy
27,030
+2,385
+10% +$418K 0.02% 458
2025
Q3 		$3.78M Buy
24,645
+1,324
+6% +$200K 0.01% 503
2025
Q2 		$3.26M Buy
23,321
+279
+1% +$39.1K 0.01% 521
2025
Q1 		$3.39M Buy
23,042
+393
+2% +$56.9K 0.01% 474
2024
Q4 		$2.97M Sell
22,649
-5,096
-18% -$713K 0.01% 501
2024
Q3 		$4.32M Buy
27,745
+10,199
+58% +$1.65M 0.02% 407
2024
Q2 		$2.74M Buy
17,546
+990
+6% +$149K 0.01% 480
2024
Q1 		$2.24M Sell
16,556
-74,072
-82% -$9.81M 0.01% 519
2023
Q4 		$12.2M Buy
90,628
+509
+0.6% +$66.2K 0.08% 145
2023
Q3 		$12.2M Sell
90,119
-17,500
-16% -$2.39M 0.09% 138
2023
Q2 		$15.4M Sell
107,619
-684
-0.6% -$101K 0.1% 110
2023
Q1 		$15M Buy
108,303
+14,201
+15% +$1.91M 0.1% 110
2022
Q4 		$12.8M Buy
94,102
+90
+0.1% +$11.3K 0.1% 127
2022
Q3 		$10.3M Buy
94,012
+4,429
+5% +$562K 0.09% 137
2022
Q2 		$11.8M Sell
89,583
-13,807
-13% -$1.81M 0.09% 117
2022
Q1 		$13.7M Sell
103,390
-55,561
-35% -$6.66M 0.09% 120
2021
Q4 		$18.5M Buy
158,951
+34,698
+28% +$4.08M 0.11% 101
2021
Q3 		$14.9M Buy
124,253
+22,776
+22% +$2.65M 0.1% 109
2021
Q2 		$12.2M Sell
101,477
-659
-0.6% -$72.3K 0.08% 126
2021
Q1 		$10.2M Sell
102,136
-66,945
-40% -$6.73M 0.08% 130
2020
Q4 		$16.9M Buy
169,081
+33,816
+25% +$3.58M 0.13% 81
2020
Q3 		$14.8M Buy
135,265
+27,591
+26% +$3.07M 0.13% 74
2020
Q2 		$9.62M Hold
107,674
– – 0.2% 61
2020
Q1 		$9.62M Buy
107,674
+6,271
+6% +$590K 0.1% 99
2019
Q4 		$10.1M Buy
101,403
+44,480
+78% +$4.19M 0.08% 109
2019
Q3 		$5.07M Buy
+56,923
New +$4.94M 0.04% 191

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Daiwa Securities Group's AZN Position: Q1 2026 in Review

Daiwa Securities Group sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 27,030 shares — an estimated $4.97M sold.

Daiwa Securities Group first reported a position in AZN in Q3 2019 and held it in 26 quarters. The position peaked at $18.5M in Q4 2021. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Daiwa Securities Group reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 27,030 AstraZeneca shares in Q1 2026, an estimated $4.97M.
  • Daiwa Securities Group first reported a position in AstraZeneca in Q3 2019 and held it in 26 quarters.
  • Daiwa Securities Group's AstraZeneca position peaked at $18.5M in Q4 2021.
  • 1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.